Literature DB >> 7785007

Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid.

G C Riise1, S Ahlstedt, S Larsson, I Enander, I Jones, P Larsson, B Andersson.   

Abstract

BACKGROUND: Bronchial inflammation in chronic bronchitis has not been characterised as well as in asthma. The present study was undertaken to assess whether a characteristic pattern of bronchial inflammatory markers could be found in patients with chronic bronchitis.
METHODS: Bronchoscopy with bronchial lavage was performed in 42 patients with chronic bronchitis and in 13 healthy controls. Twenty three of the patients had non-obstructive chronic bronchitis and 19 had chronic bronchitis and chronic obstructive pulmonary disease (COPD). Eighteen of the patients with bronchitis had recurrent infective exacerbations and 24 did not. Intrabronchial bacterial cultures were taken with a protected specimen brush.
RESULTS: Increased activity of neutrophils, fibroblasts, and eosinophils was found in the patients with chronic bronchitis as assessed by the levels of myeloperoxidase (MPO) and interleukin-8 (IL-8), hyaluronan, and eosinophil cationic protein (ECP), respectively. The levels of tryptase did not differ from the controls. High correlations were found between the levels of MPO and IL-8, as well as ECP and IL-8. No differences were found between the patients with COPD and those with non-obstructive chronic bronchitis.
CONCLUSIONS: Recruitment and activation of both neutrophils and eosinophils seem to be a characteristic of chronic bronchitis. This activation is associated with IL-8. The patients with intrabronchial cultures of Streptococcus pneumoniae had the highest individual levels of MPO, ECP, and IL-8 of all subjects in the study, indicating that colonisation with S pneumoniae could promote bronchial inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785007      PMCID: PMC474276          DOI: 10.1136/thx.50.4.360

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  36 in total

1.  Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins.

Authors:  P Venge; A Strömberg; J H Braconier; L E Roxin; I Olsson
Journal:  Br J Haematol       Date:  1978-04       Impact factor: 6.998

2.  Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters.

Authors:  A B Thompson; D Daughton; R A Robbins; M A Ghafouri; M Oehlerking; S I Rennard
Journal:  Am Rev Respir Dis       Date:  1989-12

3.  Interleukin-8 is a potent eosinophil chemo-attractant.

Authors:  J Shute
Journal:  Clin Exp Allergy       Date:  1994-03       Impact factor: 5.018

4.  Effect of bronchial lavage volume on cellular and protein recovery.

Authors:  S Lam; J C Leriche; K Kijek; D Phillips
Journal:  Chest       Date:  1985-12       Impact factor: 9.410

Review 5.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 6.  Bronchoalveolar lavage.

Authors:  H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1987-01

7.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.

Authors:  J B Richman-Eisenstat; P G Jorens; C A Hébert; I Ueki; J A Nadel
Journal:  Am J Physiol       Date:  1993-04

8.  Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria.

Authors:  S Hedges; P Anderson; G Lidin-Janson; P de Man; C Svanborg
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma.

Authors:  J Bousquet; P Chanez; J Y Lacoste; I Enander; P Venge; C Peterson; S Ahlstedt; F B Michel; P Godard
Journal:  J Allergy Clin Immunol       Date:  1991-10       Impact factor: 10.793

10.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.

Authors:  G Boman; U Bäcker; S Larsson; B Melander; L Wåhlander
Journal:  Eur J Respir Dis       Date:  1983-08
View more
  24 in total

Review 1.  Factors influencing airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Hill; S Gompertz; R Stockley
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

2.  Hyaluronan fragments contribute to the ozone-primed immune response to lipopolysaccharide.

Authors:  Zhuowei Li; Erin N Potts; Claude A Piantadosi; W Michael Foster; John W Hollingsworth
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

3.  Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.

Authors:  A Schnabel; E Csernok; J Braun; W L Gross
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 4.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

5.  Assessment of airway neutrophils by sputum colour: correlation with airways inflammation.

Authors:  R A Stockley; D Bayley; S L Hill; A T Hill; S Crooks; E J Campbell
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

6.  Inflammatory response after inhalation of bacterial endotoxin assessed by the induced sputum technique.

Authors:  J Thorn; R Rylander
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

7.  Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation.

Authors:  M A Dentener; J H J Vernooy; S Hendriks; E F M Wouters
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

8.  Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor.

Authors:  Samuel L Collins; Katharine E Black; Yee Chan-Li; Young-Hoon Ahn; Philip A Cole; Jonathan D Powell; Maureen R Horton
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-21       Impact factor: 6.914

9.  Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.

Authors:  W A Biernacki; S A Kharitonov; P J Barnes
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

Review 10.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.